China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China 
VANCOUVER, Washington, April 13, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, will hold an investment community conference call to provide an update on clinical trial and regulatory developments.
| Date: | Tuesday, April 18, 2017 | ||
| Time: | 1:00 p.m. PT / 4:00 p.m. ET | ||
| U.S./Canada Dial In: | 877-407-2986 | ||
| International Dial In: | 201-378-4916 |
A live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 60 days. Web participants are encouraged to go to the website 15 minutes prior to the start of the call to register, download and install any necessary software. The webcast can also be accessed via the following link: http://cytodyn.equisolvewebcast.com/4-18-17.
A replay of the conference call will be available until June 18, 2017. To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international); Conference ID: 13652328.
CONTACTS: Investors: LHA Jody Cain Office: 310-691-7100 E-mail: [email protected] Media: Nader Pourhassan, Ph.D. President & CEO Office: 360-980-8524 Email: [email protected]
